Liver cancer, pp.763-786, 2006. ,
Malignant tumours of the liver, Surgery (Oxford), vol.27, issue.1, pp.30-37, 2009. ,
, CA: A Cancer Journal for Clinicians, vol.65, issue.2, pp.87-108, 2012.
, BioMed Research International 9
Epidemiology of hepatocellular carcinoma in the Asia-Pacific region, Gut and Liver, vol.10, issue.3, pp.332-339, 2016. ,
Global burden of cancers attributable to infections in 2012: a synthetic analysis, The Lancet Global Health, vol.4, issue.9, pp.609-616, 2016. ,
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma, Hepatology, vol.62, issue.4, pp.1190-1200, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02044957
Hepatocellular carcinoma in India, Chinese Clinical Oncology, vol.2, issue.4, 2013. ,
Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace, Journal of Hepatology, vol.56, issue.6, pp.1384-1391, 2012. ,
Hepatocellular carcinoma: Novel molecular targets in carcinogenesis for future therapies, BioMed Research International, vol.2014, 2014. ,
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country, Journal of Hepatology, vol.66, issue.3, pp.537-544, 2017. ,
Strategies for the management of hepatocellular carcinoma, Nature Clinical Practice Oncology, vol.4, issue.7, pp.424-432, 2007. ,
Hepatocellular carcinoma: The need for progress, Journal of Clinical Oncology, vol.23, issue.13, pp.2892-2899, 2005. ,
A review of hepatocellular carcinoma (HCC) staging systems, Chinese Clinical Oncology, vol.2, issue.4, pp.33-44, 2013. ,
Liver-Directed Radiotherapy for Hepatocellular Carcinoma, Liver Cancer, vol.5, issue.3, pp.198-209, 2016. ,
Therapeutic strategies in HCC: Radiation modalities, BioMed Research International, vol.2016, 2016. ,
Systemic therapies in hepatocellular carcinoma, Digestive Diseases, vol.27, issue.2, pp.175-188, 2009. ,
Liver-directed therapies for patients with primary liver cancer and hepatic metastases, Current Treatment Options in Oncology, vol.7, issue.5, pp.399-409, 2006. ,
Emerging therapies in advanced hepatocellular carcinoma, Experimental Hematology and Oncology, vol.7, issue.77, 2018. ,
Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond, Cancer Treatment Reviews, vol.68, pp.16-24, 2018. ,
Functional imaging in liver tumours, Journal of Hepatology, vol.65, issue.5, pp.1017-1030, 2016. ,
Surgical management of noncolorectal cancer liver metastases, Cancer, vol.120, issue.20, pp.3111-3121, 2014. ,
Clinical Features of Metastatic Hepatic Malignancies, Cancer Treatment and Research, vol.168, pp.185-202, 2016. ,
Treatments for colorectal liver metastases: A new focus on a familiar concept, Critical Review in Oncology/Hematology, vol.108, pp.154-163, 2016. ,
Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: A single centre experience, Journal of Oncology, 2012. ,
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) -a single-institution retrospective analysis, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.2, pp.262-277, 2018. ,
Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms, BioMed Research International, vol.2017, 2017. ,
Transarterial chemoembolization of hepatocellular carcinoma-agents and drugs: An overview. Part 2, Expert Opinion on Drug Delivery, vol.10, issue.6, pp.799-810, 2013. ,
An Evidence-Based Multidisciplinary Approach to the Management of Hepatocellular Carcinoma (HCC): The Alberta HCC Algorithm, Canadian Journal of Gastroenterology & Hepatology, vol.24, 2010. ,
Intra-arterial radionuclide therapies for liver tumors, Seminars in Nuclear Medicine, vol.46, issue.4, pp.324-339, 2016. ,
Selective internal radiotherapy (radioembolization) and radiation therapy for HCC -Current status and perspectives, Zeitschrift für Gastroenterologie, vol.47, issue.1, pp.37-54, 2009. ,
Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides, Nature Reviews Gastroenterology & Hepatology, vol.7, issue.1, pp.41-49, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00742471
Advances in radioembolization -embolics and isotopes, Journal of Nuclear Medicine Radiation Therapy, vol.2, issue.1, pp.107-112, 2011. ,
Radioembolization with yttrium-90 microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies -Part 3: Comprehensive literature review and future direction, Journal of Vascular and Interventional Radiology, vol.17, issue.10, pp.1571-1593, 2006. ,
Yttrium-90 microspheres: a review of its emerging clinical indications, Liver Cancer, vol.4, issue.1, pp.6-15, 2015. ,
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma, Advances in Therapy, vol.33, issue.5, pp.699-714, 2016. ,
Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?, Current Treatment Options in Oncology, vol.17, issue.6, 2016. ,
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial, The Lancet Oncology, vol.18, issue.12, pp.1624-1636, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01727346
Internal radiation therapy of hepatic cancer, Diseases of the Colon & Rectum, vol.22, pp.371-375, 1979. ,
The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres, Advances in Radiation Oncology, vol.1, issue.4, pp.351-364, 2016. ,
Advances in nuclear oncology: Microspheres for internal radionuclide therapy in liver tumours, Current Medicinal Chemistry, vol.9, issue.1, pp.73-82, 2002. ,
Preparation of 32-p labelled resin microspheres for radiation treatment of tumours by intra-arterial injection, Minerva nucleare, vol.55, pp.169-174, 1964. ,
Phosphorus-32: the forgotten radiopharmaceutical?, Nuclear Medicine Communications, vol.29, issue.2, pp.95-97, 2008. ,
The relationship between effects and radiation doses of intra-arterial phosphorus-32 glass microspheres embolization therapy for patients with advanced liver cancer, Chinese journal of surgery, vol.38, issue.11, pp.837-840, 2000. ,
Technical Considerations of Phosphorous-32 Bremsstrahlung SPECT Imaging after Radioembolization of Hepatic Tumors: A Clinical Assessment with a Review of Imaging Parameters, Radiology Research and Practice, vol.2014, 2014. ,
Magnetic resonance imaging-based radiation-absorbed dose estimation of166Ho microspheres in liver radioembolization, International Journal of Radiation Oncology Biology Physics, vol.83, issue.3, pp.437-444, 2012. ,
Quantification of holmium-166 loaded microspheres: Estimating high local concentrations using a conventional multiple gradient echo sequence with S 0-fitting, Journal of Magnetic Resonance Imaging, vol.35, issue.6, pp.1453-1461, 2012. ,
Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radioembolization: A validation study, Biomedical Microdevices, vol.11, issue.4, pp.763-772, 2009. ,
Biodegradable radiotherapeutic polyester microspheres: optimization and in-vitro/in-vivo evaluation, Journal of Controlled Release, vol.18, issue.3, pp.193-203, 1992. ,
Characterization of holmium loaded alginate microspheres for multimodality imaging and therapeutic applications, Journal of Biomedical Materials Research Part A, vol.82, issue.4, pp.892-898, 2007. ,
Radioactive holmium phosphate microspheres for cancer treatment, International Journal of Pharmaceutics, vol.548, issue.1, pp.73-81, 2018. ,
166 Homicrosphere liver radiotherapy: A preclinical SPECT dosimetry study in the pig, Nuclear Medicine Communications, vol.15, issue.7, pp.545-553, 1994. ,
Production of microspheres labeled with holmium-166 for liver cancer therapy: the preliminary experience at IPEN-CNEN/SP, Proceedings of the International Nuclear Atlantic Conference -INAC, 2009. ,
Therapeutic use of 90Y microspheres, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, vol.14, issue.3, pp.233-242, 1987. ,
166Holmium-containing glass for internal radiotherapy of tumors, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, vol.18, issue.7, pp.783-790, 1991. ,
90Y-resin particlesAnimal experiments on pigs with regard to the introduction of superselective embolization therapy, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, vol.18, issue.3, pp.305-311, 1991. ,
Preparation and preliminary in vivo evaluation of 166Ho-labeled microspheres for possible use in radioembolic therapy of liver cancer, Journal of Labelled Compounds and Radiopharmaceuticals, vol.61, issue.6, pp.509-514, 2018. ,
Poly(L-lactic Acid) Microspheres Containing Neutron-Activatable Holmium-165: A Study of the Physical Characteristics of Microspheres Before and After Irradiation in a Nuclear Reactor, Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists, vol.9, issue.1, pp.149-154, 1992. ,
Surface characteristics of holmium-loaded poly(L-lactic acid) microspheres, Biomaterials, vol.26, issue.8, pp.925-932, 2005. ,
Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice, Journal of Nuclear Medicine, vol.39, issue.12, pp.2161-2166, 1998. ,
Holmium-166 poly lactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: Effects of preparation and neutron activation techniques, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.7, pp.699-704, 1999. ,
Formation and stability of lanthanide complexes and their encapsulation into polymeric microspheres, The Journal of Physical Chemistry C, vol.96, issue.21, pp.8626-8631, 1992. ,
Neutron-activated holmium-166-Poly(L-lactic acid) microspheres: A potential agent for the internal radiation therapy of hepatic tumors, Journal of Nuclear Medicine, vol.32, issue.11, pp.2139-2143, 1991. ,
Removal of chloroform from biodegradable therapeutic microspheres by radiolysis, International Journal of Pharmaceutics, vol.315, issue.1-2, pp.67-74, 2006. ,
Holmium nanoparticles: Preparation and in vitro characterization of a new device for radioablation of solid malignancies, Pharmaceutical Research, vol.27, issue.10, pp.2205-2212, 2010. ,
Holmium-loaded poly(L-lactic acid) microspheres: In vitro degradation study, Biomacromolecules, vol.7, issue.7, pp.2217-2223, 2006. ,
Production of GMP-grade radioactive holmium loaded poly(L-lactic acid) microspheres for clinical application, International Journal of Pharmaceutics, vol.311, issue.1-2, pp.69-74, 2006. ,
Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: A biodistribution study, European Journal of Nuclear Medicine and Molecular Imaging, vol.28, issue.6, pp.743-749, 2001. ,
Longterm toxicity of holmium-loaded poly(l-lactic acid) microspheres in rats, Biomaterials, vol.28, issue.31, pp.4591-4599, 2007. ,
Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs, European Journal of Nuclear Medicine and Molecular Imaging, vol.35, issue.7, pp.1259-1271, 2008. ,
, Liver Tumors: MR Imaging of Radioactive Holmium Microspheres -Phantom and Rabbit Study, vol.231, pp.491-499, 2004.
Internal radiation therapy of liver tumors: Qualitative and quantitative magnetic resonance imaging of the biodistribution of holmiumloaded microspheres in animal models, Magnetic Resonance in Medicine, vol.53, issue.1, pp.76-84, 2005. ,
Holmium-166 poly(L-lactic acid) microsphere radioembolisation of the liver: Technical aspects studied in a large animal model, European Radiology, vol.20, issue.4, pp.862-869, 2010. ,
Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial, Journal of Experimental & Clinical Cancer Research, vol.29, issue.70, 2010. ,
Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): A phase 1, dose-escalation study, The Lancet Oncology, vol.13, issue.10, pp.1025-1034, 2012. ,
In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies, Journal of Nuclear Medicine, vol.54, issue.12, pp.2093-2100, 2013. ,
99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres, European Journal of Nuclear Medicine and Molecular Imaging, vol.41, issue.10, pp.1965-1975, 2014. ,
Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres, Journal of Nuclear Medicine, vol.56, issue.6, pp.817-823, 2015. ,
Efficacy of radioembolization with 166Ho-Microspheres in salvage patients with liver metastases: A phase 2 study, Journal of Nuclear Medicine, vol.59, issue.4, pp.582-588, 2018. ,
Radiation emission from patients treated with holmium-166 radioembolization, Journal of Vascular and Interventional Radiology, vol.25, issue.12, pp.1956-1963, 2014. ,
Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: Study protocol for a randomized controlled trial, Trials, vol.17, issue.1, 2016. ,
Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (milican) for the treatment of small hepatocellular carcinoma, Clinical Cancer Research, vol.12, issue.2, pp.543-548, 2006. ,
Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma, Oncology, vol.76, issue.1, pp.1-9, 2008. ,
Rhenium-188 Production in Hospitals ,
, Generator, for Easy Use in Radionuclide Therapy, Article ID 290750, 7 pages, vol.2013, 2013.
Continued Availability of the Tungsten-188/ Rhenium-188 Generator to Enhance Therapeutic Utility of 188Re, International Journal of Nuclear Medicine Research, 2017. ,
Labeling and biodistribution of different particle materials for radioembolization therapy with 188Re, Applied Radiation and Isotopes, vol.62, issue.5, pp.745-750, 2005. ,
Preparation and properties of radioactive rhenium glass microspheres intended for in vivo radioembolization therapy, Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol.42, issue.4, pp.617-625, 1998. ,
Hepatic tumor radioembolization in a rat model using radioactive rhenium (186RE/188RE) glass microspheres, International Journal of Radiation Oncology Biology Physics, vol.44, issue.1, pp.189-199, 1999. ,
Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma, Journal of Nuclear Medicine, vol.39, issue.10, pp.1752-1757, 1998. ,
Direct injection of 188Re-microspheres in the treatment of hepatocellular carcinoma. Compared with traditional percutaneous ethanol injection: An animal study, Nuklearmedizin / Nuclear Medicine, vol.44, issue.3, pp.76-80, 2005. ,
Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation, Applied Radiation and Isotopes, vol.54, issue.6, pp.869-879, 2001. ,
188Rhe-nium(V)-dimercaptosuccinic acid loaded poly(lactic-co-glycolic)acid microspheres for targeted radiotherapy: Production and effectivity, Die Pharmazie, vol.60, issue.8, pp.583-587, 2005. ,
Radiolabelling of poly(histidine) derivatized biodegradable microspheres with the 188Re tricarbonyl complex, Nuclear Medicine Communications, vol.26, issue.5, pp.453-458, 2005. ,
Preparation and evaluation of, Journal of Labelled Compounds and Radiopharmaceuticals, vol.61, issue.8, pp.586-594, 2018. ,
Biodegradable and Multifunctional Microspheres for Treatment of Hepatoma through Transarterial Embolization, ACS Biomaterials Science & Engineering, vol.4, issue.9, pp.3425-3433, 2018. ,
Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours, European Journal of Nuclear Medicine and Molecular Imaging, vol.41, issue.2, pp.231-237, 2014. ,
68Ga and 188Re starchbased microparticles as theranostic tool for the hepatocellular carcinoma: Radiolabeling and preliminary in vivo rat studies, PLoS ONE, vol.11, issue.10, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01398433
99mTc-MAA-based dosimetry for liver cancer treated using 90Y-loaded microspheres: Known proof of effectiveness, Journal of Nuclear Medicine, vol.55, issue.8, pp.1391-1392, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01175542
Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: A promising new agent for radiotherapy, Applied Radiation and Isotopes, vol.52, issue.1, pp.63-68, 2000. ,
A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine, Applied Radiation and Isotopes, vol.62, issue.6, pp.915-918, 2005. ,
Imaging, biodistribution and efficacy evaluation of 188Re-human serum albumin microspheres via intraarterial route in an orthotopic hepatoma model, International Journal of Radiation Biology, vol.93, issue.5, pp.477-486, 2017. ,
Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization, Japanese Journal of Clinical Oncology, vol.37, issue.12, pp.942-950, 2007. ,
Initial study of radiological and clinical efficacy radioembolization using 188re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers, Medical Science Monitor, vol.20, pp.1353-1362, 2014. ,
Hepatocellular carcinoma and metastatic cancer detected by iodized oil, Radiology, vol.154, issue.1, pp.15-17, 1985. ,
Case report: Persistence of lipiodol for 13 months in metastatic deposits in the liver on computed tomography, Clinical Radiology, vol.44, issue.4, pp.273-274, 1991. ,
Exchange labelling of 'lipiodol' ultra fluids with lodine-131 and its intra-lymphatic administration with a fistula on the thoracic duct, Nature, vol.203, issue.4946, pp.777-778, 1964. ,
Intra-arterial injection of 131I-labeled Lipiodol for advanced hepatocellular carcinoma: a 7 years' experience, Nuclear Medicine Communications, vol.34, issue.7, pp.674-681, 2013. ,
131-iodine Lipiodol therapy in hepatocellular carcinoma, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol.53, issue.3, pp.348-355, 2009. ,
Dosimetry of iodine-131 ethiodol in the treatment of hepatoma, Journal of Nuclear Medicine, vol.29, issue.6, pp.1038-1044, 1988. ,
Rhenium-188 based radiopharmaceuticals for treatment of liver tumours, The Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol.53, issue.3, pp.305-310, 2009. ,
Transarterial Radionuclide Therapy with 188Re-Labelled Lipiodol, International Journal of Nuclear Medicine Research, 2017. ,
Radiolabelling of Lipiodol with generator-produced 188Re for hepatic tumor therapy, Applied Radiation and Isotopes, vol.47, issue.3, pp.267-271, 1996. ,
Biodistribution of rhenium-188 Lipiodol infused via the hepatic artery of rats with hepatic tumours, European Journal of Nuclear Medicine and Molecular Imaging, vol.23, issue.1, pp.13-17, 1996. ,
Hepatic artery injection of yttrium-90-lipiodol: biodistribution in rats with hepatoma, Journal of Nuclear Medicine, vol.37, issue.2, pp.332-335, 1996. ,
Rhenium Diamino Dithiol Complexes. III. Lipophilic Ligands for Endotherapeutic Radiopharmaceuticals, Australian Journal of Chemistry, vol.53, issue.12, p.983, 2000. ,
Lipiodol solution of a lipophilic agent, 188 Re-TDD, for the treatment of liver cancer, Nuclear Medicine and Biology, vol.28, issue.2, pp.197-204, 2001. ,
Synthesis of 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer, Nuclear Medicine Communications, vol.23, issue.3, pp.237-242, 2002. ,
Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: Preclinical study in a rabbit liver cancer model, Journal of Nuclear Medicine, vol.44, issue.12, pp.2033-2038, 2003. ,
Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol, Applied Radiation and Isotopes, vol.65, issue.1, pp.64-69, 2007. ,
Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent, p.188 ,
, Nuclear Medicine and Biology, vol.42, issue.3, pp.317-322, 2015.
Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection, Nuclear Medicine and Biology, vol.31, issue.5, pp.671-677, 2004. ,
Evaluating the potential of 188re-ecd/lipiodol as a therapeutic radiopharmaceutical by intratumoral injection for hepatoma treatment, Cancer Biotherapy and Radiopharmaceuticals, vol.24, issue.5, pp.535-541, 2009. ,
Synthesis and primary biological evaluation of 188ReN-NEMPTDD, Journal of Radioanalytical and Nuclear Chemistry, vol.277, issue.2, pp.365-369, 2008. ,
Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model, Nuclear Medicine and Biology, vol.38, issue.7, pp.1043-1052, 2011. ,
Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma, Annals of Nuclear Medicine, vol.27, issue.6, pp.532-537, 2013. ,
A kit formulation for the preparation of re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma, Nuclear Medicine Communications, vol.25, issue.7, pp.691-699, 2004. ,
A kit formulation for the labelling of lipiodol with generator-produced 188Re, Journal of Labelled Compounds and Radiopharmaceuticals, vol.47, issue.12, pp.857-867, 2004. ,
188Re-SSS/Lipiodol: development of a potential treatment for HCC from bench to bedside, International Journal of Molecular Imaging, vol.2012, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00866975
Indium-111-labeled cellular blood components: mechanism of labeling and intracellular location in human neutrophils, Journal of Nuclear Medicine, vol.18, issue.10, pp.1022-1026, 1977. ,
90Y-oxineethiodol, a potential radiopharmaceutical for the treatment of liver cancer, Applied Radiation and Isotopes, vol.58, issue.5, pp.567-573, 2003. ,
Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer, Nuclear Medicine Communications, vol.30, issue.5, pp.362-367, 2009. ,
Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: A Preliminary Animal Study, Cancer Biotherapy and Radiopharmaceuticals, vol.25, issue.5, pp.539-543, 2010. ,
Preparation and preliminary evaluation of 90Y-tropolonateLipiodol as a potential radiopharmaceutical for hepatocellular carcinoma therapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.43, p.454, 2016. ,
Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma, Applied Radiation and Isotopes, vol.94, pp.241-246, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01069619
Research on extracted 90Y with P204 in lipiodol for liver cancer, Journal of Radioanalytical and Nuclear Chemistry, vol.272, issue.3, pp.669-671, 2007. ,
-radiation exposure with 188Re-labelled pharmaceuticals, Nuklearmedizin / Nuclear Medicine, vol.44, issue.3, pp.94-98, 2005. ,
Extremity exposure in nuclear medicine therapy with 90Y-labelled substances -Results of the ORAMED project, Radiation Measurements, vol.46, issue.11, pp.1283-1286, 2011. ,
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma, Nuclear Medicine and Biology, vol.38, issue.2, pp.207-213, 2011. ,
Automation of labelling of Lipiodol with high-activity generator-produced 188Re, Applied Radiation and Isotopes, vol.69, issue.2, pp.426-430, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00752790
Development of semiautomated module for preparation of 131I labeled lipiodol for liver cancer therapy, Cancer Biotherapy and Radiopharmaceuticals, vol.32, issue.1, pp.33-37, 2017. ,
Reduction of -radiation exposure during preparation of 188Re-labelled Lipiodol for hepatocellular carcinoma treatment, Nuclear Medicine Communications, vol.33, issue.2, pp.205-208, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00867028
Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases, Radiology, vol.168, issue.2, pp.541-545, 1988. ,
Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study, Clinical Nuclear Medicine, vol.11, issue.7, pp.514-517, 1986. ,
Iodine-131-lipiodol therapy in hepatic tumours, Methods, vol.55, issue.3, pp.246-252, 2011. ,
Metaanalysis of interstitial pneumonia in studies evaluating iodine-131-labeled lipiodol for hepatocellular carcinoma using exact likelihood approach, Pharmacoepidemiology and Drug Safety, vol.20, issue.9, pp.956-963, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00740165
188Rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma -A case report, Annals, Academy of Medicine, vol.30, issue.5, pp.542-545, 2001. ,
Biodistribution and dosimetry assessments for hepatocellular carcinoma treated with 188Re-SSS Lipiodol: Preliminary results of the phase 1 trial Lip Re 1, Journal of Nuclear Medicine, vol.59, issue.1, p.602, 2018. ,
Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates, Annals, Academy of Medicine, vol.31, issue.3, pp.382-386, 2002. ,
Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.31, issue.2, pp.250-257, 2004. ,
188Re-HDD/lipiodol therapy for hepatocellular carcinoma: An activity escalation study, European Journal of Nuclear Medicine and Molecular Imaging, vol.33, issue.3, pp.344-352, 2006. ,
188Re-HDD/lipiodol therapy for hepatocellular carcinoma: A phase I clinical trial, Journal of Nuclear Medicine, vol.46, issue.1, pp.60-66, 2005. ,
188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: A feasibility study in patients with advanced cirrhosis, Journal of Nuclear Medicine, vol.46, issue.8, pp.1326-1332, 2005. ,
Transarterial radionuclide therapy with Re-188-HDD-lipiodol in case of unresectable hepatocellular carcinoma with extensive portal vein thrombosis, European Journal of Radiology Extra, vol.56, issue.2, pp.55-59, 2005. ,
Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil, Journal of Vascular and Interventional Radiology, vol.17, issue.1, pp.157-161, 2006. ,
Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol, European Journal of Gastroenterology & Hepatology, vol.18, issue.2, pp.219-223, 2006. ,
Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma, Journal of Nuclear Medicine, vol.45, issue.4, pp.612-618, 2004. ,
Intra-arterial rhenium-188 lipiodol in the treatment of inoperable hepatocellular carcinoma: results of an IAEA-Sponsored Multination Study, International Journal of Radiation Oncology Biology Physics, vol.69, issue.5, pp.1448-1455, 2007. ,
International atomic energy agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study, Seminars in Nuclear Medicine, vol.38, issue.2, pp.40-45, 2008. ,
Inoperable hepatocellular carcinoma: Transarterial 188Re HDD-labeled iodized oil for treatment -Prospective multicenter clinical trial, Radiology, vol.243, issue.2, pp.509-519, 2007. ,
Systematic review and meta-analysis of adjuvant I131 lipiodol after excision of hepatocellular carcinoma, Annals of Surgical Oncology, vol.21, issue.8, pp.2700-2707, 2014. ,
The anti-tumoral activity of neoadjuvant intra-arterial 131I-lipiodol treatment for hepatocellular carcinoma: A pilot study, Cancer Biotherapy and Radiopharmaceuticals, vol.16, issue.4, pp.333-338, 2001. ,
Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol, British Journal of Surgery, vol.90, issue.11, pp.1379-1383, 2003. ,
Radiolabeled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: Pathology of the explant livers and clinical outcome, Cancer Biotherapy and Radiopharmaceuticals, vol.20, issue.2, pp.209-214, 2005. ,
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion, CardioVascular and Interventional Radiology, vol.39, issue.3, pp.334-343, 2016. ,
Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma, CardioVascular and Interventional Radiology, vol.30, issue.6, pp.1156-1165, 2007. ,
I-131-Lipiodol therapy in liver neoplasms, Hybridoma, vol.18, issue.1, pp.83-85, 1999. ,
Selective Radionuclide Localisation in Primary Liver Tumours, HPB Surgery, vol.7, p.16, 1994. ,
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds, European Journal of Nuclear Medicine and Molecular Imaging, vol.38, issue.7, pp.1393-1406, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00814020
Localization of Lipiodol-radioiodine in hepatic metastases from renal cell carcinoma, British Journal of Radiology, vol.67, issue.800, pp.822-824, 1994. ,
In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines, British Journal of Cancer, vol.79, issue.11-12, pp.1665-1671, 1999. ,